We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 07, 2021

Overall Survival Associated With Oncology Drugs Approved for Genomic Indications

European Journal of Cancer

 

Additional Info

European Journal of Cancer
Overall survival for oncology drugs approved for genomic indications
Eur. J. Cancer 2021 Nov 21;[EPub Ahead of Print], A Haslam, MS Kim, V Prasad

Further Reading